Comparative Efficacy and Toxicity of Gemcitabine-Cisplatin vs. Gemcitabine-Carboplatin in Metastatic Carcinoma of the Urinary Bladder: A Retrospective Review.
GC demonstrates improved efficacy compared to GCa in terms of PFS and OS, although this comes with renal toxicity. GCa can be a reasonable option for patients not receiving cisplatin.
Authors
- Sudhir Kumar Rawal
- Arpit Jain
- Siddhant Swamy
- Varun Goel
- Nivedita Patnaik
- Dharmistha Basu
- Vineet Talwar
Institutions
- Max Super Speciality Hospital (IN)
- Rajiv Gandhi Cancer Institute and Research Centre (IN)
- BLK Super Speciality Hospital (IN)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-01
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00